Creaspine's SupStance™ PEEK VBR gains FDA approval
The SupStance™ PEEK VBR system has received FDA 510(k) approval on December 18, 2007.
US surgeries schedule starts January 2008.Bordeaux, January 4, 2008 / Creaspine SAS / -- Bordeaux-based Creaspine SAS, a research and innovation start-up and manufacturer of spinal implant devices, has received on December 18, 2007 approval from the FDA to market the new PEEK-Optima tumor and trauma VBR system.
"We are pleased to bring this new technology to the US market", declared Franck Tricot, Creaspine's Director of Business Development™. “Our goal was to develop a real distraction solution that would help surgeons to be effective in achieving their surgical objectives when completing a VBR procedure”.
The SupStance™ PEEK VBR system will be distributed exclusively in the US by Saint-Louis, Missouri-based SpineSource, Inc.
Spine Innovation News Engine
|
